This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

King Pharmaceuticals, Oil Rigs: Hot Trends

(Information on Pfizer's acquisition of King Pharmaceuticals and offshore oil drilling regulations updated in today's Hot Trends article.)

NEW YORK ( TheStreet) -- "King Pharmaceuticals" is a hot search topic today following the news that Pfizer (PFE - Get Report) has struck a $3.6 billion deal to acquire pain-reliever specialist King Pharmaceuticals (KG).

>> King Pharmaceuticals, Pain Therapeutics: Biotech Winners

The agreement helped boost shares of Pain Therapeutics (PTIE), an early-stage painkiller developer. Pain has teamed with King on the development of Pain's lead drug candidate Remoxy, which is currently in clinical trials.

The companies have a licensing agreement for Remoxy, a "strong painkiller" which, according to Pain's press reports, has a "unique formulation designed to reduce potential risks of unintended use." Pfizer is likely interested in King's research on and involvement with "abuse-resistant" pain drugs.

"Offshore oil rigs" is a heavily search phrase today after the news that the U.S. government lifted the moratorium on deepwater drilling today.

>>Energy Winners: Gulf of Mexico Oil Companies Alive and Well

The Obama administration put the restrictions in place following the disastrous BP (BP - Get Report) oil spill in the Gulf of Mexico.

Drilling companies must file for new permits before they can start drilling again. In order to be cleared for operations, companies must meet a set of safety requirements. The CEO of each company must comply with new regulations in efforts to reduce the chance of future accidents.

"Internet TV" is a hot search topic today as Google (GOOG) prepares to launch its highly anticipated Internet TV service, Google TV, this fall.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BP $36.97 0.00%
PFE $36.06 0.00%
PTIE $1.89 0.00%
AAPL $121.30 0.00%
FB $94.01 0.00%

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs